National Guideline Clearinghouse | Guidelines by Topic: Breast Neoplasms

National Guideline Clearinghouse | Guidelines by Topic: Breast Neoplasms

Guidelines by Topic

Disease/Condition > Diseases (2457) > Neoplasms (610) > Neoplasms by Site (474) >

Breast Neoplasms (64)

Narrow:

Breast Neoplasms, Male (4)
Carcinoma, Ductal, Breast (5)
Hereditary Breast and Ovarian Cancer Syndrome (1)

1-20 of 64   Next >
1.   Eribulin for the treatment of locally advanced or metastatic breast cancer. 2012 Apr. NGC:009074 National Institute for Health and Clinical Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s) Compare Selected
2.   Management of gynecologic issues in women with breast cancer. 2012 Mar. NGC:008958 American College of Obstetricians and Gynecologists - Medical Specialty Society. View all guidelines by the developer(s) Compare Selected
3.   Diagnosis of breast disease. 1994 Jan (revised 2012 Jan). NGC:008960 Institute for Clinical Systems Improvement - Nonprofit Organization. View all guidelines by the developer(s) Compare Selected
4.   Recommendations on screening for breast cancer in average-risk women aged 40–74 years. 1994 Jan (revised 2011 Nov). NGC:009058 Canadian Task Force on Preventive Health Care - National Government Agency [Non-U.S.]. View all guidelines by the developer(s) Compare Selected
5.   Fractionation for whole breast irradiation: an American Society for Radiation Oncology (ASTRO) evidence-based guideline. 2011 Sep 1. NGC:009045 American Society for Radiation Oncology - Professional Association. View all guidelines by the developer(s) Compare Selected
6.   Breast cancer screening. 2003 Apr (revised 2011 Aug). NGC:008655 American College of Obstetricians and Gynecologists - Medical Specialty Society. View all guidelines by the developer(s) Compare Selected
7.   ACR Appropriateness Criteria® conservative surgery and radiation—stage I and II breast carcinoma. 1996 (revised 2011). NGC:008468 American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s) Compare Selected
8.   ACR Appropriateness Criteria® ductal carcinoma in situ. 1996 (revised 2011). NGC:008881 American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s) Compare Selected
9.   ACR Appropriateness Criteria® locally advanced breast cancer. 1996 (revised 2011). NGC:008469 American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s) Compare Selected
10.   ACR Appropriateness Criteria® non-spine bone metastases. 1996 (revised 2011). NGC:008877 American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s) Compare Selected
11.   ACR Appropriateness Criteria® stage I breast carcinoma. 1996 (revised 2011). NGC:008851 American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s) Compare Selected
12.   American Society of Clinical Oncology clinical practice guideline update on the role of bone-modifying agents in metastatic breast cancer. 2000 Mar (revised 2011). NGC:008441 American Society of Clinical Oncology - Medical Specialty Society. View all guidelines by the developer(s) Compare Selected
13.   Breast cancer screening clinical practice guideline. 2010 Aug. NGC:008538 Kaiser Permanente Care Management Institute - Managed Care Organization. View all guidelines by the developer(s) Compare Selected
14.   Adjuvant ovarian ablation in the treatment of premenopausal women with early stage invasive breast cancer. 2010 Jul 6. NGC:009198 Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s) Compare Selected
15.   American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. 2010 Apr. NGC:007851 American Society of Clinical Oncology - Medical Specialty Society; College of American Pathologists - Medical Specialty Society. View all guidelines by the developer(s) Compare Selected
16.   Zoledronic acid as adjuvant therapy in combination with adjuvant endocrine therapy for premenopausal women with early-stage hormone receptor positive breast cancer. 2010 Jan 25. NGC:007887 Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s) Compare Selected
17.   ACR Appropriateness Criteria® local-regional recurrence (LR) and salvage surgery—breast cancer. 1996 (revised 2010). NGC:008446 American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s) Compare Selected
18.   ACR Appropriateness Criteria® nonpalpable mammographic findings (excluding calcifications). 1996 (revised 2010). NGC:007916 American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s) Compare Selected
19.   ACR–ASTRO practice guideline for the performance of high-dose-rate brachytherapy. 1996 (revised 2010). NGC:008423 American College of Radiology - Medical Specialty Society; American Society for Radiation Oncology - Professional Association. View all guidelines by the developer(s) Compare Selected
20.   ACR–SPR practice guideline for the performance of tumor scintigraphy (with gamma cameras). 1996 (revised 2010). NGC:008421 American College of Radiology - Medical Specialty Society; Society for Pediatric Radiology - Medical Specialty Society. View all guidelines by the developer(s) Compare Selected
1-20 of 64   Next >

21-40 of 64   < Previous | Next >
21.   1) Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. 2) December 2009 addendum. 1996 (revised 2009 Nov; addendum released 2009 Dec). NGC:007533 U.S. Preventive Services Task Force - Independent Expert Panel. View all guidelines by the developer(s) Compare Selected
22.   The prophylactic use of filgrastim in patients with breast cancer. 2009 Oct 1. NGC:007883 Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s) Compare Selected
23.   The continued use of trastuzumab beyond disease progression in patients with metastatic breast cancer. 2009 Aug 17. NGC:007691 Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s) Compare Selected
24.   Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). 2009 Jul. NGC:009050 American Society for Radiation Oncology - Professional Association. View all guidelines by the developer(s) Compare Selected
25.   American Society of Clinical Oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction. 1999 (revised 2009 Jul). NGC:007469 American Society of Clinical Oncology - Medical Specialty Society. View all guidelines by the developer(s) Compare Selected
26.   The use of bevacizumab in metastatic breast cancer. 2009 Apr 17. NGC:007694 Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s) Compare Selected
27.   Hereditary breast and ovarian cancer syndrome. 2009 Apr. NGC:007204 American College of Obstetricians and Gynecologists - Medical Specialty Society. View all guidelines by the developer(s) Compare Selected
28.   Advanced breast cancer. Diagnosis and treatment. 2003 May (revised 2009 Feb). NGC:007179 National Collaborating Centre for Cancer - National Government Agency [Non-U.S.]. View all guidelines by the developer(s) Compare Selected
29.   Early and locally advanced breast cancer. Diagnosis and treatment. 2006 Aug (revised 2009 Feb). NGC:007180 National Collaborating Centre for Cancer - National Government Agency [Non-U.S.]. View all guidelines by the developer(s) Compare Selected
30.   ACR Appropriateness Criteria® palpable breast masses. 1996 Sep (revised 2009). NGC:007758 American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s) Compare Selected
31.   Breast cancer. In: Suspected cancer in primary care: guidelines for investigation, referral and reducing ethnic disparities. 2009 Sep 1. NGC:007548 New Zealand Guidelines Group - Nonprofit Organization. View all guidelines by the developer(s) Compare Selected
32.   Ductal carcinoma in situ. In: Management of early breast cancer. 2009 Aug. NGC:007564 New Zealand Guidelines Group - Nonprofit Organization. View all guidelines by the developer(s) Compare Selected
33.   Follow-up. In: Management of early breast cancer. 2009 Aug. NGC:007565 New Zealand Guidelines Group - Nonprofit Organization. View all guidelines by the developer(s) Compare Selected
34.   General principles of care. In: Management of early breast cancer. 2009 Aug. NGC:007558 New Zealand Guidelines Group - Nonprofit Organization. View all guidelines by the developer(s) Compare Selected
35.   Hormone therapy and breast cancer. In: Menopause and osteoporosis update 2009. 2006 Feb (revised 2009 Jan). NGC:006972 Society of Obstetricians and Gynaecologists of Canada - Medical Specialty Society. View all guidelines by the developer(s) Compare Selected
36.   Radiotherapy. In: Management of early breast cancer. 2009 Aug. NGC:007561 New Zealand Guidelines Group - Nonprofit Organization. View all guidelines by the developer(s) Compare Selected
37.   Recommendations from the EGAPP Working Group: can tumor gene expression profiling improve outcomes in patients with breast cancer? 2009 Jan. NGC:006965 Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group - Independent Expert Panel. View all guidelines by the developer(s) Compare Selected
38.   Special issues. In: Management of early breast cancer. 2009 Aug. NGC:007566 New Zealand Guidelines Group - Nonprofit Organization. View all guidelines by the developer(s) Compare Selected
39.   Staging. In: Management of early breast cancer. 2009 Aug. NGC:007559 New Zealand Guidelines Group - Nonprofit Organization. View all guidelines by the developer(s) Compare Selected
40.   Systemic therapy: chemotherapy regimens. In: Management of early breast cancer. 2009 Aug. NGC:007562 New Zealand Guidelines Group - Nonprofit Organization. View all guidelines by the developer(s) Compare Selected
21-40 of 64   < Previous | Next >

41-60 of 64   < Previous | Next >
41.   Systemic therapy: endocrine therapies. In: Management of early breast cancer. 2009 Aug. NGC:007563 New Zealand Guidelines Group - Nonprofit Organization. View all guidelines by the developer(s) Compare Selected
42.   Use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers. 2009. NGC:007630 National Academy of Clinical Biochemistry - Professional Association. View all guidelines by the developer(s) Compare Selected
43.   Guideline implementation for breast healthcare in low- and middle-income countries: breast healthcare program resource allocation. 2008 Oct 15. NGC:007438 Breast Health Global Initiative - International Agency. View all guidelines by the developer(s) Compare Selected
44.   Guideline implementation for breast healthcare in low- and middle-income countries: diagnosis resource allocation. 2008 Oct 15. NGC:007436 Breast Health Global Initiative - International Agency. View all guidelines by the developer(s) Compare Selected
45.   Guideline implementation for breast healthcare in low- and middle-income countries: early detection resource allocation. 2008 Oct 15. NGC:007435 Breast Health Global Initiative - International Agency. View all guidelines by the developer(s) Compare Selected
46.   Guideline implementation for breast healthcare in low- and middle-income countries: treatment resource allocation. 2008 Oct 15. NGC:007437 Breast Health Global Initiative - International Agency. View all guidelines by the developer(s) Compare Selected
47.   Guideline implementation for breast healthcare in low-income and middle-income countries. 2008 Oct 15. NGC:006767 Breast Health Global Initiative - International Agency. View all guidelines by the developer(s) Compare Selected
48.   Long-term follow-up guidelines for survivors of childhood, adolescent, and young adult cancers. Sections 137-146: cancer and general health screening. 2003 Sep (revised 2008 Oct). NGC:007574 Children's Oncology Group - Medical Specialty Society. View all guidelines by the developer(s) Compare Selected
49.   Long-term follow-up guidelines for survivors of childhood, adolescent, and young adult cancers. Sections 38-91: radiation. 2003 Sep (revised 2008 Oct). NGC:007570 Children's Oncology Group - Medical Specialty Society. View all guidelines by the developer(s) Compare Selected
50.   Fulvestrant for systemic therapy of locally advanced or metastatic breast cancer in postmenopausal women: guideline recommendations. 2008 Sep 25. NGC:006748 Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s) Compare Selected
51.   The role of aromatase inhibitors in adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: guideline recommendations. 2005 Oct 25 (revised 2008 Feb 26). NGC:006433 Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s) Compare Selected
52.   ACR Appropriateness Criteria® postmastectomy radiotherapy. 1996 (revised 2008). [NGC Update Pending] NGC:007142 American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s) Compare Selected
53.   American Society of Clinical Oncology 2007 update recommendations for the use of tumor markers in breast cancer. 1997 (revised 2007 Oct). NGC:006050 American Society of Clinical Oncology - Medical Specialty Society. View all guidelines by the developer(s) Compare Selected
54.   Common breast problems. 2007 Oct. NGC:006199 University of Michigan Health System - Academic Institution. View all guidelines by the developer(s) Compare Selected
55.   Oncology evidence-based nutrition practice guideline. 2007 Oct. NGC:006621 Academy of Nutrition and Dietetics - Professional Association. View all guidelines by the developer(s) Compare Selected
56.   Risk assessment and genetic counseling for hereditary breast and ovarian cancer: recommendations of the National Society of Genetic Counselors. 2007 Jun. NGC:006247 National Society of Genetic Counselors - Medical Specialty Society. View all guidelines by the developer(s) Compare Selected
57.   Screening mammography for women 40 to 49 years of age: a clinical practice guideline from the American College of Physicians. 2007 Apr 3. NGC:005578 American College of Physicians - Medical Specialty Society. View all guidelines by the developer(s) Compare Selected
58.   (1) ACS guidelines for breast cancer screening: update 2003. (2) American Cancer Society Guideline for breast screening with MRI as an adjunct to mammography (2007). 1997 (revised 2003; addendum released 2007 Mar). NGC:006083 American Cancer Society - Disease Specific Society. View all guidelines by the developer(s) Compare Selected
59.   The role of gemcitabine in the management of metastatic breast cancer: a clinical practice guideline. 2006 Jun 27 (revised 2007 Jan 22). NGC:005583 Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s) Compare Selected
60.   Gemcitabine for the treatment of metastatic breast cancer. 2007 Jan. NGC:005740 National Institute for Health and Clinical Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s) Compare Selected
41-60 of 64   < Previous | Next >

61-64 of 64   < Previous
61.   Magnetic resonance imaging for breast cancer screening, pre-operative assessment, and follow-up. 2010 Oct (republished 2012 Jan). NGC:008706 Alberta Health Services, Cancer Care - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s) Compare Selected
62.   Care of the HIV-infected transgender patient. 2011 Jul. [NGC Update Pending] NGC:008812 New York State Department of Health - State/Local Government Agency [U.S.]. View all guidelines by the developer(s) Compare Selected
63.   Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline. 2009 Sep. NGC:007430 The Endocrine Society - Disease Specific Society. View all guidelines by the developer(s) Compare Selected
64.   Heavy menstrual bleeding. 2007 Jan. NGC:005499 National Collaborating Centre for Women's and Children's Health - National Government Agency [Non-U.S.]. View all guidelines by the developer(s) Compare Selected
61-64 of 64   < Previous